Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
gene mutation
Research
Amish-linked gene variant reduces risk of heart disease
A genetic variant linked to Old Order Amish people that reduces LDL cholesterol and a blood clotting protein could inform new heart disease therapies.
Kyle LaHucik
Dec 6, 2021 8:50am
Vanderbilt team offers new clues for targeting p53
Sep 1, 2021 9:50am
Illumina CEO says U.S. behind on COVID-19 surveillance: CNBC
Jan 22, 2021 12:16pm
ESMO: Blueprint preps trial of drug for triple-mutant NSCLC
Sep 21, 2020 9:25am
Outsmarting COVID-19 by analyzing RNA in single cells
Aug 21, 2020 9:20am
Could the anti-cancer gene p53 be a target in kidney cancer?
Dec 20, 2019 9:42am